Efferocytosis-related gene IL33 predicts prognosis and immune response and mediates proliferation and migration in vitro and in vivo of breast cancer
BackgroundBreast cancer (BRCA) has a high incidence among women, with poor prognosis and high mortality, which is increasing year by year. Efferocytosis is a process of phagocytosis of abnormal cells and is of great value in tumor research. Our study seeks to create a predictive model for BRCA using...
Saved in:
Main Authors: | Xiao He, Xianjie Cheng, Zhun Zhang, Lanhui Chen, Changjun Xie, Mengjie Tang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1533571/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
IL-33 signaling is dispensable for the IL-10-induced enhancement of mast cell responses during food allergy
by: Dylan Krajewski, et al.
Published: (2025-01-01) -
Immunomodulatory effect of efferocytosis at the maternal–fetal interface
by: Hui Tao, et al.
Published: (2025-01-01) -
Efferocytosis and inflammation: a bibliometric and systematic analysis
by: Xin Cao, et al.
Published: (2025-02-01) -
REDD1 mediates HDM-induced nuclear-cytoplasmic translocation and release of IL-33 in airway epithelial cells by downregulating Nrf2
by: Tian Luo, et al.
Published: (2025-02-01) -
IRG1/itaconate enhances efferocytosis by activating Nrf2-TIM4 signaling pathway to alleviate con A induced autoimmune liver injury
by: Liwu Zeng, et al.
Published: (2025-02-01)